Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Prospective Longitudinal Cohort Study of Vasculitis Patients

Cohort Study of Vasculitis Patients: Longitudinal Study for the Assessment of Presentation, Comorbidities, Management, Outcomes and Damage

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

VASCO is a prospective observational cohort study which aim to describe the presentation, comorbidities, management, outcomes and damage of vasculitis patients, from the analysis of the clinical, biological and immunological data.

Who May Be Eligible (Plain English)

Who May Qualify: - Adult patients (age over 18 years), - Patients with vasculitis, as defined in the Chapel Hill International Nomenclature as revised in 2012, - Patients included at an active phase of the disease, either the initial flare or a relapse, - Patients who have been informed and have signed the consent - Pregnant and breastfeeding women may be included in the study, - Affiliated to a social security system (beneficiary or entitled person). Who Should NOT Join This Trial: - Refusal of consent or inability to obtain consent, - A patient who is insane or not entitled, for psychiatric reasons or intellectual impairment, to receive information about the protocol and to give willing to sign a consent form, - Patient under guardianship / curators - Patient on state medical assistance (AME) - Hemoglobin less than 7 g/dl at the time of sampling, - Hemoglobin level less than 9 g/dl at the time of sampling if the patient has respiratory or cardiovascular disease, - Patient weighs less than 18 kg. - Parallel participation in an interventional protocol is permitted. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Adult patients (age over 18 years), * Patients with vasculitis, as defined in the Chapel Hill International Nomenclature as revised in 2012, * Patients included at an active phase of the disease, either the initial flare or a relapse, * Patients who have been informed and have signed the consent * Pregnant and breastfeeding women may be included in the study, * Affiliated to a social security system (beneficiary or entitled person). Exclusion Criteria: * Refusal of consent or inability to obtain consent, * A patient who is insane or not entitled, for psychiatric reasons or intellectual impairment, to receive information about the protocol and to give informed consent, * Patient under guardianship / curators * Patient on state medical assistance (AME) * Hemoglobin less than 7 g/dl at the time of sampling, * Hemoglobin level less than 9 g/dl at the time of sampling if the patient has respiratory or cardiovascular disease, * Patient weighs less than 18 kg. * Parallel participation in an interventional protocol is permitted.

Treatments Being Tested

OTHER

Data collection

Medical data collection at M0, M3, M6, M9 and M12 then every 6 months until M60 and at each vascularitis relapse

OTHER

Biological samples and data collection

Biological samples at M0, M6, M12, M24 and at each relapse until M60

Locations (1)

Service de médecine interne, Hôpital Cochin, AP-HP
Paris, France